Abstract: A motion control method, a sweeping machine, and a computer-readable storage medium are provided. The method includes: controlling a second wheel to rotate around a first wheel so that second wheel moves in a direction for passing through a passage, in response to a sweeping machine locating at an entrance of the passage; controlling the sweeping machine to move backward in response to a distance between the sweeping machine and the obstacle being less than a predetermined first distance threshold; and controlling the sweeping machine to rotate at a first predetermined angle around a center so that first wheel moves in the direction for passing through the passage, in response to the distance between the sweeping machine and the obstacle being larger than or equal to the predetermined first distance threshold, and returning to the step of controlling the second wheel until the sweeping machine passes through the passage.

Abstract: Methods of synthesizing (R)-N-(4-(4-(3-chloro-5-ethyl-2-methoxyphenyl) piperazin-1-yl)-3-hydroxybutyl)-1H-indole-2-carboxamide are described.

Abstract: The present invention provides a power system for a roller apparatus, including a unidirectional resistance module. The unidirectional resistance module includes a unidirectional transmission assembly and a resistance member. The unidirectional resistance module provides a unidirectional resistance when a curtain body is released from a rolling tube. This resistance compensates for the tolerance between the self-weight of the curtain body and the total rebound force of the power coil spring module, allowing the curtain body to stay stable at a desired height and improving the smoothness in retracting the curtain body of a cordless roller apparatus.

Abstract: A process for the preparation of racemic and optically active (1E,NE)-N-(1-aminoethylidene)-3-(4-chlorophenyl)-4-phenyl-N?-((4-(trifluoromethyl)phenyl)sulfonyl)-4,5-dihydro-1H-pyrazole-1-carboximidamide in high enantiomerical purity is provided.

Abstract: A rolling curtain includes a rolling tube, a curtain body, a first power component, and a second power component. The rolling tube has a first end and a second end opposite to the first end. The curtain body is wound around the rolling tube, the first power component is located at the first end of rolling tube, and the first power component has a motor and a transmission component, the transmission component is connected to the rolling tube and rotating with rolling tube. The second power component is located at the second end, and includes at least one power module connected to the rolling tube and rotating coaxially with the rolling tube, the power module includes a module chamber, a connecting rod, and at least one spring member, with an inner end of the spring member connected to the connecting rod and an outer end connected to the module chamber.

Abstract: A rolling curtain includes a rolling tube, a curtain body, a first power component, and a second power component. The rolling tube has a first end and a second end opposite to the first end. The curtain body is wound around the rolling tube, the first power component is located at the first end of rolling tube, and the first power component has a motor and a transmission component, the transmission component is connected to the rolling tube and rotating with rolling tube. The second power component is located at the second end, and includes at least one power module connected to the rolling tube and rotating coaxially with the rolling tube, the power module includes a module chamber, a connecting rod, and at least one spring member, with an inner end of the spring member connected to the connecting rod and an outer end connected to the module chamber.

Abstract: The present invention provides small-molecule inhibitors of BMP signaling and compositions and methods for inhibiting BMP signaling. These compounds and compositions may be used to modulate cell growth, differentiation, proliferation, and apoptosis, and thus may be useful for treating diseases or conditions associated with BMP signaling, including inflammation, cardiovascular disease, hematological disease, cancer, and bone disorders, as well as for modulating cellular differentiation and/or proliferation. These compounds and compositions may also be used to treat subjects with Sjögren's syndrome, or diffuse intrinsic pontine glioma (DIPG).

Abstract: The present invention provides small-molecule inhibitors of BMP signaling and compositions and methods for inhibiting BMP signaling. These compounds and compositions may be used to modulate cell growth, differentiation, proliferation, and apoptosis, and thus may be useful for treating diseases or conditions associated with BMP signaling, including inflammation, cardiovascular disease, hematological disease, cancer, and bone disorders, as well as for modulating cellular differentiation and/or proliferation. These compounds and compositions may also be used to treat subjects with Sjögren's syndrome, or diffuse intrinsic pontine glioma (DIPG).

Abstract: A process for the preparation of racemic and optically active (1E,NE)-N-(1-aminoethylidene)-3-(4-chlorophenyl)-4-phenyl-N?-((4-(trifluoromethyl)phenyl)sulfonyl)-4,5-dihydro-1H-pyrazole-1-carboximidamide in high enantiomerical purity is provided.

Abstract: A polarizer sheet, a display panel and a display device are provided. The polarizer sheet includes a supporting layer, a polarizing layer, and an electrically conductive layer. The display panel includes the polarizer sheet, a color filter substrate, an array substrate, and a silver adhesive layer. The display device includes the display panel. The invention reduces a used amount of silver adhesive, reduces cost, increases contacting area between the polarizer sheet and the color filter substrate, and increases a proportion of a screen, so that the polarizer sheet can be applied to a full screen narrow border mobile phone.

Abstract: The present invention provides small-molecule inhibitors of BMP signaling and compositions and methods for inhibiting BMP signaling. These compounds and compositions may be used to modulate cell growth, differentiation, proliferation, and apoptosis, and thus may be useful for treating diseases or conditions associated with BMP signaling, including inflammation, cardiovascular disease, hematological disease, cancer, and bone disorders, as well as for modulating cellular differentiation and/or proliferation. These compounds and compositions may also be used to treat subjects with Sjögren's syndrome, or diffuse intrinsic pontine glioma (DIPG).

Abstract: The present invention provides small-molecule inhibitors of BMP signaling and compositions and methods for inhibiting BMP signaling. These compounds and compositions may be used to modulate cell growth, differentiation, proliferation, and apoptosis, and thus may be useful for treating diseases or conditions associated with BMP signaling, including inflammation, cardiovascular disease, hematological disease, cancer, and bone disorders, as well as for modulating cellular differentiation and/or proliferation. These compounds and compositions may also be used to treat subjects with Sjögren's syndrome, or diffuse intrinsic pontine glioma (DIPG).